網路內科繼續教育
有效期間:民國 89年08月01日 89年08月15日

    Case Discussion

     A 52-year-old man was admitted to the hospital because of fever, shaking chills, productive cough, epistaxis, and hemoptysis for 2 days. The patient was well until one month prior to admission, when he developed pale appearance and petechiae over bilateral lower extremities. He was diagnosed as acute promyelocytic leukemia with disseminated intravascular coagulation after a series of examinations, including bone marrow aspiration, peripheral blood smear and coagulation study. Genetic study showed a t (15,17) translocation. Then, all-trans retinoic acid (ATRA) was administered. An episode of left lower lobe pneumonia was also noted. He was put on ceftazidime and tobramycin. Fever and productive cough gradually subsided in one week.

      Concurrent chemotherapy with idarubicin and cytarabine (I2A2) was given on the 9th and 10th days after all-trans retinoic acid treatment. Intermittent fever without shaking chills or rigors developed nine days after all-trans retinoic acid treatment. Besides, he experienced progressive edema with arthralgia over bilateral ankles, gross hematuria, bloody stool and aggravated hemoptysis. Acute oliguric renal failure and progressive respiratory distress were also noted two weeks after all-trans retinoic acid treatment. He then underwent further evaluation.

     He was a building security without history of exposure to radiation or chemicals. He had hyperuricemia for years without regular medical control. He denied habits of smoking and alcohol consumption. His mother had hypertension and diabetes mellitus and died of heart disease.

     The body temperature was 40 ℃ at examination. The pulse rate was 120/min. The respiration rate was 28/min. The blood pressure was 110/70 mmHg. Inspiratory crackles over bilateral upper and lower lung fields with mild decreased lung sound over bilateral lower lung fields were found. The heart examination was unremarkable. The bowel sound was normoactive. The abdomen was soft without tenderness. There was no hepatosplenomegaly. There was no lymphadenopathy. Bilateral pedal swelling and petechiae were noted. A rectal examination showed external hemorrhoids and no palpable mass.

 < Laboratory Data >

1. CBC + D/C:
Days after ATRA treatment RBC(M/μl) Hb(g/dl) Hct(%) MCV(fl) MCHC(%) PLT(K/μl) WBC( /μl)
D01 2.14 6.8 20.2 94.4 33.7 75 4630
D09 2.81 8.6 25.3 90.0 34.0 110 3420
D13 2.62 8.2 23.7 90.5 29.3 63 2000
D23 2.61 7.6 22.1 84.7 34.4 45 1910
D28 3.26 9.5 27.2 83.4 34.9 61 550
D34 2.83 8.2 23.9 84.5 34.3 120 4240

  
Days after ATRA treatment Myelo-blast(%) Promye-locyte(%) Myelo-cyte(%) Meta(%) Band(%) Seg(%) Eos(%) Baso(%) Mono(%) Lym(%)
D01 1 92 0 0 0 0 0 0 0 7
D09 0 28 21 4 5 6 0 0 0 36
D13 0 0 5 7 10 47 3.5 5.5 2 20
D23 0 0 1 0 6 85 0 0 1 7
D28 0 0 0 0 4 62 0 0 8 26
D34 0 0 0 0 0 71.8 0.2 0.2 17.9 9.9

2. BCS
Days after ATRA treatment A/G(gm/dl) Bil(T/D)(mg/dl) AST(U/l) ALT(U/l) ALP(U/l) r-GT(U/l)  LDH(U/l) BUN(mg/dl) Cre(mg/dl) UA(mg/dl)
D01 3.1/3.3 0.8/0.3 24 14 129 75 1501 18.9 0.9 6.1
D08 3.3/3.9 0.7/0.2 44 39 181 70 1049 18.8 0.9 4.6
D17 2.9/3.7 0.9/0.2 21 12 170 54 754 48.1 2.8 8.0
D21 2.7/3.4 1.1/0.7 19 6 139 59 894 98 7.3 7.7
D23 2.9/3.8 1.1/0.7 21 8 138 61 897 117.5 8.9 7.6
D26 3.0/4.0 0.8/0.5 13 4 147 75   196.1 11.2 10.4
D52 3.2/3.9 0.6/0.2 8 9       53.9 2.2 5.2

3. PT/PTT and DIC profile
Days after ATRA treatment PT(sec) PTT(sec) 3P test D-dimer(μg/ml) FDP (μg/ml) Fibrinogen(mg/dl)
D01 17.4/11.9 37.3/32.0 4+ 16-32 160-320 188
D08 12.1/11.8 31.3/33.2
-
0.5-1 10-20 318
D16     4+ 6.02 20-40 296
D22 16.8/11.5 42.0/32.3 2+ 1.65 10-20 393
D26 16.6/11.5 35.1/31.3
-
1.50 10-20 400

4. Urinalysis
Days after ATRA treatment PH Protein(mg%) Sugar(mg/dl) OB Ketone Bili-rubin Urobili-nogen RBC(/HPF) WBC(/HPF) Cast
D02 6.5 >300
-
3+
-
-
0.1 60~70 2-5 Hy(2~3)
D10 7.0 30
-
3+
-
-
0.1 12-15 3-5
-
D15 6.0 30
-
3+
-
-
0.1 Num 2-4 RBC dys-morphism (-)Cylindoid (+)
D24 6.0 30
-
3+
-
-
0.1 Num 1-3
-

5. Blood gas
Days after ATRA treatment PH PCO2(mmHg) PO2(mmHg) HCO3(mEq/l) BE(mEq/l)  
D23 7.37 26.9 186.1 15.1 -9.0 FiO2 60%, 10 L/min
D26 7.33 23.2 316.5 11.9 -12.8 FiO2 36%, 5 L/mim

6. Blood culture:
(2000/01/24, D01) No aerobic & anaerobic pathogens
(2000/02/08, D16) No aerobic & anaerobic pathogens
(2000/02/14, D22) No aerobic & anaerobic pathogens

7. Sputum culture:
(2000/01/22, D-02) Klebsiella pneumoniae
(2000/02/10, D18) Sternotrophomonas maltophilia

8. Bone marrow examination
(2000/01/24, D01) Acute promyelocytic leukemia, t (15;17)
(2000/02/14, D22) Acute promyelocytic leukemia, in good partial remission (2000/02/29, D37) Hypocellular marrow, moderate, in complete remission

9. Renal echo: parenchymal renal disease

Course and treatment

      After fever work-up, the antibiotics were shifted to cefepime, amikacin, and clarithromycin under the impression of bilateral pedal cellulitis. However, the fever persisted. Vancomycin, imipenem, and fluconazole were used to replace cefepime, amikacin and clarithromycin. Cultures from blood and urine did not yield microorganism. The respiratory distress became more and more severe. Acute renal failure was noted two weeks after Tretinoin (ATRA) therapy. Furosemide (240 mg/day iv infusion) was given for oliguria and vancomycin was discontinued. Serum aminoglycoside levels were within therapeutic ranges and uric acid levels within normal limits. The urine output increased about three days later and furosemide was tapered. However, exacerbated azotemia, accompanied with uremic symptoms occurred and hemodialysis was performed. Serial chest X-ray showed progressive infiltration over bilateral lung fields(圖一). High resolution computerized tomography(圖二 ) revealed multifocal infiltration of bilateral lungs, consolidation at left lower lung, increased infiltration with focal ground glass opacities at right lower lung, and bilateral pleural effusion. Cardiac echo showed fair LV contractility without pericardial effusion. Due to intermittent high fever refractory to strong antibiotics, progressive respiratory distress, acute renal failure, increased pulmonary infiltrate with pleural effusion, all-trans retinoic acid syndrome was suspected. Tretinoin was discontinued and dexamethasone ( 20mg/day) was administered. Fever subsided 12 hours after the treatment. Besides, the respiratory distress also improved dramatically. The follow-up chest X-ray showed gradual resolution of pulmonary infiltrate.He also recovered from the episode of acute renal failure soon. Bone marrow examination thirty-seven days after all-trans retinoic acid treatment showed complete remission of acute promyelocytic leukemia.

繼續教育考題
1.
(B)
What is the most striking character of acute promyelocytic leukemia ?
ACutaneous chloroma
BDisseminated intravascular dissemination
CGum hypertrophy
DMeningeal syndrome
2.
(D)
What is the most common chromosomal abnormality of acute promyelocytic leukemia ?
A t (8;21)
B t (9;22)
C–5/del (5q)
D t (15;17)
3.
(C)
Presently, which one of the following treatment modality for acute promyelocytic leukemia carries a higher rate of remission and disease-free survival?
AChemotherapy alone
BRadiotherapy
CAll-trans retinoic acid (ATRA) and chemotherapy
DAll- trans retinoic acid alone
4.
(D)
Which one of the following statement about all-trans retinoic acid (ATRA) is wrong?
AATRA may reduce self-renewal of APL blasts and increase cell maturation of committed precursors
BHypertriglycemia is one of the adverse effects of ATRA
C In the presence of ATRA, APL blasts may increase the gene expression of normal RARα
DATRA may induce exacerbation of disseminated intravascular coagulation
5.
(A)
Which clinical manifestation may not suggest all-trans retinoic acid (ATRA) syndrome?
AAbdominal pain
BOliguria
CRespiratory distress
DFever
6.
(D)
Which one is not a possible pathogenesis of ATRA syndrome?
AExpression of intercellular adhesion molecule 1 (ICAM-1) by endothelial cells
BRelease of various cytokines that cause capillary leak syndrome
CExpression of CD13, CD11a, CD11b, and ICAM-2 by leukemic cells for tissue infiltration
DNone of the above
7.
(C)
Which one of the following parameters may be a predictor for the development of ATRA syndrome?
APatient's age
BPML/RARαisoform
CHigh WBC count at diagnosis
DMean fibrinogen level
8.
(D)
Which of the following chest x-ray findings can exclude the possibility of ATRA syndrome?
AReticular and ground glass shadowing
BPleural effusions
CSmall, irregular peripheral nodules in the lung fields
DNone of the above
9.
(A)
The most efficient treatment for ATRA syndrome is
ACorticosteroids
BNonsteroidal anti-inflammatory drugs
CAlkylating agents
DGold preparations
10.
(D)
Which one of the following statements is wrong?
AAll-trans retinoic acid is a highly effective agent for inducing complete remission in patients with acute promyelocytic leukemia
BA high index of suspicion is necessary in the diagnosis of all-trans retinoic acid syndrome
CPrompt administration of dexamethasone is critical for all-trans retinoic acid syndrome, once the first sign of unexplained dyspnea, fever, weight gain, and pulmonary infiltrate is established
DNone of the above


Top of Page